Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

Investing

AbbVie : ABBV

All AbbVie Articles

613 Articles

Chris Lange | Jan 26, 2018 at 4:08 PM EST

Friday’s Biggest Winners and Losers in the S&P 500

Friday was a positive day for the U.S. markets. We are currently in the midst of the fourth quarter earnings…

Chris Lange | Jan 26, 2018 at 8:50 AM EST

AbbVie’s Q4 Boosted by Strong Segment Results

AbbVie reported better-than-expected fourth-quarter financial results before the markets opened on Friday.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jan 25, 2018 at 10:00 AM EST

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…

Chris Lange | Jan 21, 2018 at 10:20 AM EST

Netflix, Ford and More Big Earnings to Watch For This Week

24/7 Wall St. has put together a preview of Netflix, Ford, AbbVie and other top companies reporting their latest quarterly…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 6, 2018 at 8:55 AM EST

20 More Biopharma Catalysts Coming in 2018

Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves…

Jon C. Ogg | Jan 4, 2018 at 9:20 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap…

Jon C. Ogg | Dec 28, 2017 at 11:20 AM EST

10 Things That Could Wreck the Bull Market in Stocks in 2018

Is it finally time to consider the old adage that "nothing lasts forever" for the bull market as we enter…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 27, 2017 at 10:55 AM EDT

Why AbbVie Won Big in Q3, and Can Keep Winning

AbbVie reported better-than-expected third-quarter before the markets opened on Friday due to strong sales of Humira and Imbruvica.

1 … 23 24 25 26 27 … 41

AbbVie : ABBV

All AbbVie Articles

Friday’s Biggest Winners and Losers in the S&P 500

AbbVie’s Q4 Boosted by Strong Segment Results

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Netflix, Ford and More Big Earnings to Watch For This Week

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

10 Things That Could Wreck the Bull Market in Stocks in 2018

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Why AbbVie Won Big in Q3, and Can Keep Winning

Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

Live: Will Intuitive Surgical Smash Tonight’s Q2 Earnings After 29% YTD Decline?

I’m 66 with only $10k saved and no pension. Dave Ramsey mapped out how I can own a house and build $350k by 76

Your $5 Copay Depends on One Word: ‘Preferred.’ Pharmacy Networks Reshuffle Every January

SpaceX at $135: Why You Should Buy SpaceX Ahead of the Planned Starship “Explosion”

I'm 66 with only $10k saved and no pension. Dave Ramsey mapped out how I can own a house and build $350k by 76

Your $5 Copay Depends on One Word: 'Preferred.' Pharmacy Networks Reshuffle Every January

I’m 66 with only $10k saved and no pension. Dave Ramsey mapped out how I can own a house and build $350k by 76

Your $5 Copay Depends on One Word: ‘Preferred.’ Pharmacy Networks Reshuffle Every January

AbbVie : ABBV

All AbbVie Articles

Friday’s Biggest Winners and Losers in the S&P 500

AbbVie’s Q4 Boosted by Strong Segment Results

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Netflix, Ford and More Big Earnings to Watch For This Week

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

10 Things That Could Wreck the Bull Market in Stocks in 2018

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Why AbbVie Won Big in Q3, and Can Keep Winning

Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

Live: Will Intuitive Surgical Smash Tonight’s Q2 Earnings After 29% YTD Decline?

I’m 66 with only $10k saved and no pension. Dave Ramsey mapped out how I can own a house and build $350k by 76

Your $5 Copay Depends on One Word: ‘Preferred.’ Pharmacy Networks Reshuffle Every January

SpaceX at $135: Why You Should Buy SpaceX Ahead of the Planned Starship “Explosion”

Featured Reads

I'm 66 with only $10k saved and no pension. Dave Ramsey mapped out how I can own a house and build $350k by 76

Your $5 Copay Depends on One Word: 'Preferred.' Pharmacy Networks Reshuffle Every January